Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Searle

Showing results (261-270 of 268) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 268 results.
Health Security|October 22, 2024
They Will Come, You Must Build It: A Modified Delphi Process Applied to Preparing Acute Care Facilities Infrastructure for High-Consequence Infectious DiseasesJustin Chan, Eileen F Searle, Dmitry Khodyakov, et al.
Health Security|April 28, 2022
Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic ResponseJonathan D Grein, Jennifer A Garland, Christa Arguinchona, et al.
The Western Journal of Emergency Medicine|December 11, 2025
National Survey on Infection Prevention and Control in United States Emergency DepartmentsLaya Dasari, Molly L Paras, Samantha L Pellicane, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Annals of Internal Medicine|November 7, 2022
Contact Tracing and Exposure Investigation in Response to the First Case of Monkeypox Virus Infection in the United States During the 2022 Global Monkeypox OutbreakErica S Shenoy, Sharon B Wright, Deborah N Barbeau, et al.
Pageof 27

Showing results (261-270 of 268) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Health Security|October 22, 2024
They Will Come, You Must Build It: A Modified Delphi Process Applied to Preparing Acute Care Facilities Infrastructure for High-Consequence Infectious DiseasesJustin Chan, Eileen F Searle, Dmitry Khodyakov, et al.
Health Security|April 28, 2022
Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic ResponseJonathan D Grein, Jennifer A Garland, Christa Arguinchona, et al.
The Western Journal of Emergency Medicine|December 11, 2025
National Survey on Infection Prevention and Control in United States Emergency DepartmentsLaya Dasari, Molly L Paras, Samantha L Pellicane, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Clinical and Experimental Pharmacology & Physiology|November 30, 2004
Nitroreductase: a prodrug-activating enzyme for cancer gene therapyPeter F Searle, Ming-Jen Chen, Longqin Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Annals of Internal Medicine|November 7, 2022
Contact Tracing and Exposure Investigation in Response to the First Case of Monkeypox Virus Infection in the United States During the 2022 Global Monkeypox OutbreakErica S Shenoy, Sharon B Wright, Deborah N Barbeau, et al.
Pageof 27